Results 131 to 140 of about 581,151 (252)
The genetic events that lead to the development of benign and low malignant potential (LMP) tumors from normal ovarian surface epithelium are not well understood.
Ward, Bruce G. +5 more
core +1 more source
A Case Report of Pseudomyxoma Peritonei Arising From Primary Mucinous Ovarian Neoplasms. [PDF]
Joseph R +4 more
europepmc +1 more source
Recent Insights into Mucinous Ovarian Carcinoma
Ovarian mucinous tumors represent a group of rare neoplasms with a still undefined cell of origin but with an apparent progression from benign to borderline to carcinoma.
Laura Carrassa +3 more
core +1 more source
Technical limitations often let dominant signals overshadow rare cell types and fine‐grained heterogeneity in spatial transcriptomics. SemanticST, a graph neural network using multi‐semantic graph fusion and a novel min‐cut loss, recovers these subtle patterns.
Roxana Zahedi +7 more
wiley +1 more source
Laparoscopic Surgery for Ovarian Neoplasms - What is Possible, What is Useful? [PDF]
Droste A, Anic K, Hasenburg A.
europepmc +1 more source
IGF2BP1 promotes gemcitabine resistance in pancreatic cancer by stabilizing m6A‐modified FTH1 transcripts and protecting them in stress granules, thereby suppressing ferroptosis. Pharmacological inhibition of IGF2BP1 disrupts this protective pathway, restores ferroptotic sensitivity, and enhances gemcitabine efficacy in resistant tumors.
Ying‐Qin Zhu +10 more
wiley +1 more source
The Histopathological Patterns of Ovarian Neoplasms in Different Age Groups: A Retrospective Study in a Tertiary Care Center. [PDF]
Farag NH +6 more
europepmc +1 more source
In human oral keratinocytes, OTUD6A promoted cell migration by deubiquitinating and stabilizing PRDX1. Conversely, OTUD6A deficiency reduced PRDX1 stability, triggering mitochondrial dysfunction and aggravating OU progression. ABSTRACT Oral ulcers (OU), as the most highly prevalent and recurrent oral mucosal lesion, have an unclear pathogenesis that ...
Xiaoyu Sun +15 more
wiley +1 more source
Introduction: Poly ADP-ribose polymerase (PARP) inhibitors are used as maintenance therapy for recurrent ovarian cancer, but their long-term safety, especially the risk of therapy-related myeloid neoplasms, remains a concern. Here, we report a
Yurika Yamada +2 more
doaj +1 more source
Educational Case: Ovarian neoplasms: A series of educational cases to review malignancies of epithelial, stromal, and germ cell origin. [PDF]
Tumas JB, Chan J.
europepmc +1 more source

